MarketResearchReports.Biz presents this most up-to-date research on “PharmaSphere: Emerging Biotechnologies – Antisense RNAi Therapeutics Market Analysis”
GlobalDatas “PharmaSphere: Emerging Biotechnologies – Antisense RNAi Therapeutics Market Analysis” report is an essential source of information and analysis on the RNA interference (RNAi) therapy field. Using detailed company data, deal analysis, corporate strategy, and market trends, GlobalData provides an in-depth analysis of the current and future growth drivers of the RNAi therapy market. The report discusses the key factors shaping and driving the RNAi therapy business, and provides insights into the competitive landscape and emerging strategies expected to significantly influence the market positions of companies currently involved in the development and commercialization of RNAi therapeutics.
Key Questions Answered
– What are the drivers of the RNAi therapy field?
– Who are the leading companies involved in the development of RNAi therapies?
– What are the major trends in RNAi clinical trials?
– What specific therapeutic areas and indications are receiving the most clinical research?
– What specific business development activities are taking place in terms of partnerships or mergers and acquisitions (M&As)?
– Has investor confidence been restored in the antisense/RNAi therapy field?
– This report provides market developments across the RNAi therapy field, including clinical trials, deals, and pipeline investments
– Investment examined from both industry and financial communities
– Clinical trials activity examined across phase of development, therapy area, and indication.
– This report offers a deep dive into the synergies behind partnering and acquisition activities
– Deals examined across geography, entity type, company, financial advisor, phase of development, therapy area, indication, and mechanism of action
– Pipeline profiles of 25 leading biotech companies developing RNAi therapeutics
Download Sample Copy of This Report at: http://www.marketresearchreports.biz/sample/sample/373085
Reasons to buy
– Identify the key players in the RNAi market.
– Analyze and track the strategies that companies are using to strengthen their position in the RNAi therapy field; independent source for due diligence.
– Organize your sales and marketing strategy to identify companies with proprietary technologies in order to maximize opportunities for licensing, partnership, investment, or takeover.
– Understand the flow of investment from capital markets into the RNAi therapy field.
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 Report Scope 13
2.2 Companies Mentioned 14
2.3 Related Reports 14
3 Antisense RNAi Therapy Overview 15
3.1 What is Antisense Therapy? 15
3.1.1 Mechanisms 16
3.2 The Second Era of RNAi 17
4 Clinical Trials 19
4.1 Overview 19
4.2 Company 20
4.3 Phase of Development 22
4.4 Therapy Area 24
4.5 Indication 27
4.5.1 Cardiovascular: Atherosclerosis 29
4.5.2 CNS: Duchenne Muscular Dystrophy 30
4.5.3 Infectious Diseases: Hepatitis Infections 32
4.6 Investigators 34
4.6.1 Specialty 34
4.6.2 Region 35
MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.
Browse Latest Industry Press Release at: http://www.marketresearchreports.biz/pressreleases
90 State Street, Suite 700
Albany, NY 12207
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz